Infection and cervical intraepithelial neoplasia

International Journal of Gynecological Cancer

Volumn 9, Issue 3, 1999, Pages 177-186

  Boyle, D C M ^a   Smith, J R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cervix neoplasm; Infection

Indexed keywords

CANCER RISK; CHLAMYDIA TRACHOMATIS; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINITIS; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

EID: 0033009350     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99007.x     Document Type: Review

References (89)

1. Koss L, Durfee G. Unusual patterns of squamous epithelium of the uterine cervix: Cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci 1956; 63: 1245-61.
2. Meisels A, Fortin R. Condylomatous lesions of the cervix and cytologic patterns. Acta Cytol 1976; 20: 505-9.
3. Purola E, Savia E. Cytology of gynecologic condyloma accuminata. Acta Cytol 1977; 21: 26-31.
4. Bosch F, Munoz N, de Sanjose S. Risk factors for cervical cancer in Columbia and Spain. Int J Cancer 1992; 52: 750-8.
5. Azocar J, Abad S, Acosta H. Prevalence of cervical dysplasia and HPV infection according to sexual behaviour. Int J Cancer 1990; 45: 622-5.
6. Rotkin I. Relation of adolescent coitus to cervical cancer risk. JAMA 1962; 179: 486-91.
7. Peters R, Thomas D, Hagan D. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles county. J Natl Cancer Inst 1986; 77: 1063-77.
8. Coppleson M, Reid B. Aetiology of squamous carcinoma of the cervix. Obstet Gynecol 1968; 32: 432.
9. Ley C, Bauer H, Reingold A. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83: 997-1003.
10. Schiffman M, Bauer H, Hoover R. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
11. Ho G, Burk R, Klein R, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
12. Lorincz A, Reid R, Jenson A. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79: 328-37.
13. Kurman R, Schiffman M, Lancaster W. Analysis of individual human papillomavirus types in cervical neoplasia: A possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988; 159: 293-6.
14. Terry G, Ho L, Jenkins D. Definitions of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by simple PCR technique. Arch Virol 1993; 128: 123-33.
15. Cox J, Lorincz A, Schiffman M. HPV testing by hybrid capture appears to be useful in triaging women with a cytological diagnosis of ASCUS. Am J Obstet Gynecol 1995; 172: 946-54.
16. Cuzick J, Terry G, Ho L, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high grade cervical epithelial neoplasia. Br J Cancer 1994; 69: 167-71.
17. Cullen A, Reid R, Campion M, Lorincz A. Analysis of the physical state of different human papilloma virus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-12.
18. Romanczuk H, Howley P. Disruption of either E2 or the E2 regulatory gene of human papilloma virus type 16 increases viral immortalisation capacity. Proc Natl Acad Sci USA 1992; 89: 3159-63.
19. Werness B, Levine A, Howley P. Association of human papilloma virus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9.
20. Livingstone L, White A, Sprouse J, Livanos E, Jacks T, Tisty T. Altered cell cycle arrest and gene amplification accompany loss of wild type p53. Cell 1992; 70: 923-35.
21. Barton S, Madden P, Jenkin J. The effect of smoking on cervical intraepithelial immunity: A mechanism for neoplastic change? Lancet 1988; ii: 652-4.
22. Bavin P, Giles G, Deery A. Use of semi-quantitative PCR for human papilloma virus type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 1993; 67: 602-5.
23. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345: 1533-6.
24. Lehtinen M, Dillner J, Knekt P, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case-control study. Br Med J 1996; 312: 537-8.
25. Borysiewicz L, Fiander A, Nimako M, Wilkinson G, Westmoreland D, et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cancer. Lancet 1996; 347: 1523-7.
26. Landers R, O'Leary J, Crowley M. Epstein-Barr virus in normal, premalignant and malignant lesions of the uterine cervix. J Clin Pathol 1993; 46: 931-5.
27. Sixbey J, Vesterinen E, Nedrud J. Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 1983; 306: 480-3.
28. Hilton D, Brown L, Pringle J. Absence of Epstein-Barr virus in carcinoma of the cervix. Cancer 1993; 72: 1946-8.
29. Payne S, Kernohan M, Walker F. Absence of in situ hybridisation evidence for latent or lytic-phase Epstein-Barr virus infection of preinvasive squamous lesions of the cervix. J Pathol 1995; 176: 221-6.
30. Smith J, Kitchen V, Botcherby M. Is HIV infection associated with an increase in the prevalence of cervical neoplasia? Br J Obstet Gynaecol 1993; 100: 149-53.
31. van den Brule A, Walboomers J, Meijer C. Epstein-Barr virus as a co-factor in cervical carcinogenesis? J Pathol 1995; 176: 219-20.
32. Bradbeer C. Is infection with HIV a risk factor for CIN? Lancet 1987; ii: 1277-8.
33. Schafer A, Friedman W, Mielke M. The increased frequency of cervical dysplasia-neoplasia in women infected with human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991; 164: 593-9.
34. Spurrett B, Jones S, Stewart G. Cervical dysplasia and HIV infection. Lancet 1988; i: 237-8.
35. Byrne M, Taylor-Robinson D, Harris J. Cervical dysplasia and HIV infection. Lancet 1988; I: 239.
36. Friedman W. HIV infection and cervical neoplasia. Gerburtschulze Frauersheilkd 1989; 49: 997-1000.
37. Mandelblatt J, Fahs M, Garibaldi K. Associations between HIV infection and cervical neoplasia: Implications for clinical care of women at risk for both conditions. AIDS 1992; 6: 173-8.
38. Byrne M, Taylor-Robinson D, Munday P, Harris J. The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 1989; 3: 379-82.
39. Henry M, Stanley M, Cruikshank S, Carson L. Association of human immunodeficiency virus induced suppression with human papillomavirus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol 1989; 160: 350-2.
40. Maggwa B, Hunter D, Mbugua S. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS 1993; 7: 733-8.
41. Langley C, Benga-De E, Critchlow C. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high risk African women. AIDS 1996; 10: 413-7.
42. Schrager L, Freidland G, Maude D. Cervical and vaginal squamous abnormalities in women infected with the human immunodeficiency virus. J AIDS 1989; 2: 570-5.
43. Fruchter R, Maiman M, Sillman F. Characteristics of cervical intraepithelial neoplasia in women with human immunodeficiency virus. Am J Obstet Gynecol 1994; 171: 531-7.
44. Laga M, Icenogle J, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia - Opportunistic complication of HIV infection. Int J Cancer 1992; 50: 45-8.
45. Sun X, Ellerbrock T, Lungu O, Chiasson M, Bush T, Wright T. Human papillomavirus in human immunodeficiency virus seropositive women. Obstet Gynecol 1995; 85: 680-6.
46. Adachi A, Fleming I, Burk R, Ho G, Klein R. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: A prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993; 81: 372-7.
47. Johnson J, Burnett A, Willet G. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus infected women. Obstet Gynecol 1992; 29: 321-7.
48. Conti M, Agarossi A, Parazzini F. HPV, HIV infection and risk of cervical intraepithelial neoplasia in former drug abusers. Gynecol Oncol 1993; 49: 344-8.
49. Petry K, Scheffel D, Bode U. Cellular immunodeficiency enhances the progression of human papillomavirus associated cervical lesions. Int J Cancer 1994; 57: 836-40.
50. Maiman M, Fruchter R, Serur E. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus seropositive women. Obstet Gynecol 1993; 82: 170-4.
51. Wright T, Koulos J, Schnoll F. Cervical neoplasia in women infected with the human immunodeficiency virus: Outcome after loop electrosurgical excision. Gynecol Oncol 1994; 55: 253-8.
52. Deleted in proof.
53. Branca M, Delfino A, Rossi E. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. Eur J Gynaecol Oncol 1995; 5: 410-7.
54. Spinillo A, Tenti P, Zappatore R. Langerhans cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol 1993; 48: 210-3.
55. Olaitan A, Johnson M, MacLean A, Poulter L. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS 1996; 10: 759-64.
56. Barton S, Maddox P, Smith J. A study of Langerhans cells in cervical epithelium of women with HIV infection. Proceedings from 1990 International Conference on AIDS. San Francisco, CA. 1990.
57. Francheschi S, Doll R, Gallwey J. Genital warts and cervical neoplasia: An epidemiological study. Br J Cancer 1983; 48: 621-8.
58. Hildesheim A, Mann B, Brinton L. Herpes simplex virus type 2: A possible interaction with human papillomaviruses 16/18 in the development of invasive cervical cancer. Int J Cancer 1991; 49: 335-40.
59. di Paolo J, Woodworth C, Popescu N. HSV-2 induced tumorgenicity in HPV-16 immortalised human genital keratinocytes. Virology 1990; 177: 777-9.
60. Zur Hausen H. Human genital cancer: Synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 1983; II: 1370-2.
61. Koffa M, Koumantakis E, Ergazaki M. Association of herpes virus infection with the development of genital cancer. Int J Cancer 1995; 63: 58-62.
62. Eglin R, Sharp F, Maclean A. Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms. Cancer Res 1981; 41: 3597.
63. Vecchione A, Cermele C, Giovagnoli M. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol 1994; 55: 343-8.
64. Galloway A, McGoogan E. The oncogenic potential of herpes simplex virus: The evidence for a 'hit and run' mechanism. Nature 1983; 302: 21-4.
65. Huang J, Naylor B. Cytomegalovirus infection of the cervix detected by cytology and histology: A report of five cases. Cytopathology (Abstract) 1991; 4: 237-41.
66. Gideon K, Zaharopoulos P, Cytomegalovirus endocervicitis diagnosed by cervical smear. Diag Cytopathol (Abstract) 1991; 7: 625-7.
67. Wales N, Nordin A, Newell A, Smith J, Barton S, Nelson M. Cytomegalovirus in the genital tract of HIV-seropositive women. (Abstract) AIDS 1996; 10: 802-3.
68. Zhang Z, Begg C. Is Trichomonas vaginalis a cause of cervical intraepithelial neoplasia? Results from a combined analysis of 24 studies, Int J Epidemiol 1994; 23: 682-90.
69. Sardana S, Sodhani P, Agarwal S. Epidemiologic analysis of Trichomonas vaginalis in inflammatory smears. Acta Cytol 1994; 38: 693-7.
70. Yap E, Ho T, Chan Y. Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med 1995; 71: 402-4.
71. Gram I, Macaluso M, Churchill J, Stalsberg H. Trichomonas vaginalis and human papillomavirus infection and the incidence of cervical intraepithelial neoplasia grade III. Cancer Causes Control 1992; 3: 231-6.
72. Harington J. Epidemiology and aetiology of cancer of the uterine cervix, including the detection of carcinogenic N-nitrosamines in the human vaginal vault. S Afr Med J 1975; 49: 449-55.
73. Smith J, Murdoch J, Carrington D. Prevalence of Chlamydia trachomatis infection in women having cervical smear tests. Br Med J 1991; 302: 82-4.
74. Koutsky L, Holmes K, Critchlow C. Cohort study of risk of cervical intraepithelial neoplasia grade 2 or 3 associated with cervical papillomavirus infection. N Engl J Med 1992; 327: 1272-8.
75. Schacter J, Hill E, King E. Chlamydia trachomatis and cervical neoplasia. JAMA 1982; 248: 2134-9.
76. de Sanjose S, Munoz N, Bosch F. Sexually transmitted agents and cervical neoplasia in Columbia and Spain, Int J Cancer 1994; 56: 358-63.
77. Allderling T, Jordan S, Boardman R. Association of human papillomavirus and chlamydia infections with incidence of cervical neoplasia. Acta Cytol 1985; 29: 653-60.
78. Mader C, Sherman K, Beckman A. History of circumcision, medical conditions and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85: 19-12.
79. Josey W, Lambe D. Epidemiologic characteristics of women infected with Corynebacterium vaginale (Hae-mophilus vaginalis). J Am Venereal Dis Assoc 1976; 3: 9-13.
80. Mead P. Cervical-vaginal flora of women with invasive cervical cancer. JAMA 1978; 52: 601-4.
81. Byrne M, Turner M, Griffiths M. Evidence that patients presenting with dyskaryotic cervical smears should be screened for genital tract infections other than human papilloma virus infection. Eur J Obstet Gyn Reprod Biol 1991; 41: 129-33.
82. Platz-Christensen J, Sundstrom E, Larsson P. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1994; 73: 586-8.
83. Peters N, van Leeuvan A, Peters W. Bacterial vaginosis is not important in the etiology of cervical neoplasia: A survey on women with dyskaryotic smears. Sex Trans Dis 1995; 22: 296-302.
84. Guijon F, Paraskevas M, Rand F. Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia. Int J Obstet Gynecol 1992; 37: 185-91.
85. Uthayakumar S, Boyle D, Barton S, Nyagam A, Smith J. Bacterial vaginosis and cervical intraepithelial neoplasia - Cause or coincidence? J Obstet Gynaecol 1998; 18: 574-6.
86. McNichol P, Paraskevas M, Guijon F. Variability of polymerase chain reaction based detection of human papillomavirus DNA is associated with the composition of vaginal microbial flora. J Med Virol 1994; 43: 194-200.
87. Chen K, Amsel R, Eschenbach D, Holmes K. Biochemical diagnosis of vaginitis: Determination of diamines in vaginal fluid. J Infect Dis 1982; 145: 337-45.
88. Pavic N. Is there a local production of nitrosamines by the vaginal microflora in anaerobic vaginosis/Trichomoniasis? Med Hypoth 1982; 15: 433-6.
89. Boyle D, Barton S, Pollock J, et al. Does bacterial vaginosis cause cervical intraepithelial neoplasia? (Abstract) 1998; Viewed at BV98 - International conference of researchers studying bacterial vaginosis, Aspen, CO. October 1998.